Biblio

Export 1398 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is P  [Clear All Filters]
2015
H. Liu-Seifert, Siemers, E., Price, K., Han, B., Selzler, K. J., Henley, D., Sundell, K., Aisen, P., Cummings, J., Raskin, J., and Mohs, R., “Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 205-14, 2015.
C. Balducci, Paladini, A., Micotti, E., Tolomeo, D., La Vitola, P., Grigoli, E., Richardson, J. C., and Forloni, G., “The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.”, J Alzheimers Dis, 2015.
Q. Zhao, Roberts, R. O., Ding, D., Cha, R., Guo, Q., Meng, H., Luo, J., Machulda, M. M., V Pankratz, S., Wang, B., Christianson, T. J. H., Aakre, J. A., Knopman, D. S., Boeve, B. F., Hong, Z., and Petersen, R. C., “Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 47, no. 1, pp. 167-76, 2015.
Q. Zhao, Roberts, R. O., Ding, D., Cha, R., Guo, Q., Meng, H., Luo, J., Machulda, M. M., V Pankratz, S., Wang, B., Christianson, T. J. H., Aakre, J. A., Knopman, D. S., Boeve, B. F., Hong, Z., and Petersen, R. C., “Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 47, no. 1, pp. 167-76, 2015.
A. J. Hanson, Bayer, J. L., Baker, L. D., Cholerton, B., VanFossen, B., Trittschuh, E., Rissman, R. A., Donohue, M. C., Moghadam, S. H., Plymate, S. R., and Craft, S., “Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 205-18, 2015.
H. H. Hansen, Fabricius, K., Barkholt, P., Niehoff, M. L., Morley, J. E., Jelsing, J., Pyke, C., Knudsen, L. Bjerre, Farr, S. A., and Vrang, N., “The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, 2015.
N. Kemppainen, Joutsa, J., Johansson, J., Scheinin, N. M., Någren, K., Rokka, J., Parkkola, R., and Rinne, J. O., “Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 123-33, 2015.
R. Migliaccio, Agosta, F., Possin, K. L., Canu, E., Filippi, M., Rabinovici, G. D., Rosen, H. J., Miller, B. L., and Gorno-Tempini, M. Luisa, “Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, 2015.
L. S. Pimentel, Allard, S., Carmo, S. Do, Weinreb, O., Danik, M., Hanzel, C. E., Youdim, M. B., and A Cuello, C., “The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 2, pp. 373-83, 2015.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., “A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
K. E. Pike, Zeneli, A., Ong, B., Price, S., and Kinsella, G. J., “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
K. E. Pike, Zeneli, A., Ong, B., Price, S., and Kinsella, G. J., “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
C. Peters-Libeu, Campagna, J., Mitsumori, M., Poksay, K. S., Spilman, P., Sabogal, A., Bredesen, D. E., and John, V., “sAβPPα is a Potent Endogenous Inhibitor of BACE1.”, J Alzheimers Dis, vol. 47, no. 3, pp. 545-55, 2015.
C. Peters-Libeu, Campagna, J., Mitsumori, M., Poksay, K. S., Spilman, P., Sabogal, A., Bredesen, D. E., and John, V., “sAβPPα is a Potent Endogenous Inhibitor of BACE1.”, J Alzheimers Dis, vol. 47, no. 3, pp. 545-55, 2015.
F. Licastro, Raschi, E., Carbone, I., and Porcellini, E., “Variants in Antiviral Genes are Risk Factors for Cognitive Decline and Dementia.”, J Alzheimers Dis, 2015.
2014
B. Dubois, Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. Luis, Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M. - O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., and Cummings, J. L., “Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.”, Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
A. R. Haeusler, Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M. - S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., Rothstein, J. D., and Wang, J., “C9orf72 nucleotide repeat structures initiate molecular cascades of disease.”, Nature, vol. 507, no. 7491, pp. 195-200, 2014.
A. R. Haeusler, Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M. - S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., Rothstein, J. D., and Wang, J., “C9orf72 nucleotide repeat structures initiate molecular cascades of disease.”, Nature, vol. 507, no. 7491, pp. 195-200, 2014.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., “Plasma phospholipids identify antecedent memory impairment in older adults.”, Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., “Plasma phospholipids identify antecedent memory impairment in older adults.”, Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
T. Lu, Aron, L., Zullo, J., Pan, Y., Kim, H., Chen, Y., Yang, T. - H., Kim, H. - M., Drake, D., X Liu, S., Bennett, D. A., Colaiácovo, M. P., and Yankner, B. A., “REST and stress resistance in ageing and Alzheimer's disease.”, Nature, vol. 507, no. 7493, pp. 448-54, 2014.
S. Hoon Choi, Kim, Y. Hye, Hebisch, M., Sliwinski, C., Lee, S., D'Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., Klee, J. B., Zhang, C., Wainger, B. J., Peitz, M., Kovacs, D. M., Woolf, C. J., Wagner, S. L., Tanzi, R. E., and Kim, D. Yeon, “A three-dimensional human neural cell culture model of Alzheimer's disease.”, Nature, vol. 515, no. 7526, pp. 274-8, 2014.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
S. A. Villeda, Plambeck, K. E., Middeldorp, J., Castellano, J. M., Mosher, K. I., Luo, J., Smith, L. K., Bieri, G., Lin, K., Berdnik, D., Wabl, R., Udeochu, J., Wheatley, E. G., Zou, B., Simmons, D. A., Xie, X. S., Longo, F. M., and Wyss-Coray, T., “Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.”, Nat Med, vol. 20, no. 6, pp. 659-63, 2014.
2013
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., “Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.”, Neuron, vol. 78, no. 4, pp. 631-43, 2013.

Pages